Close
Close
Treatment Database
reslizumab
Trade Name Cinquil
Orphan Indication Hypereosinophilic syndrome
USA Market Approval
USA Designation Date 12-01-2011
Sponsor Teva Pharmaceuticals, Inc.
41 Moores Road, P. O. Box 4011
Frazer, Pennsylvania, 19355
More about Idiopathic hypereosinophilic syndrome
Free Newsletter
Related Videos
by Abidemi Uruejoma
467 views